Join
Live feed
·
INSIDERFilingvia Quantisnow
Evelo Biosciences Inc. logo

SEC Form 4: Plinio Mark D. was granted 1,250 shares, increasing direct ownership by 50% to 3,750 units

ByQuantisnow·Wall Street's wire, on your screen.
EVLO· Evelo Biosciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EVLO (Evelo Biosciences Inc.) and more on Quantisnow.